Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790062 · ClinicalTrials.gov registry record · Phase 4
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,798
- Enrollment target
NCT00790062: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.
NCT00790062 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,798 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (247% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00790062, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,798 participants
- Enrollment target
Study Summary
This is a double-blind 3-arm randomized clinical trial to determine whether higher dose oxytocin regimens (compared to the standard regimen) reduce the frequency of uterine atony and postpartum hemorrhage after vaginal delivery. Uterine atony is a loss of tone in the uterine musculature which can cause acute postpartum hemorrhage, which is the major cause of maternal mortality worldwide. Oxytocin is routinely administered postpartum in the US and effectively reduces uterine atony. The optimal dose of oxytocin for vaginal delivery is not known.
Primary Outcome
the number of subjects with any treatment of uterineatony or hemorrhage.
Interventions
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,798 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
What the finished NCT00790062 record still lists
NCT00790062 is an interventional study that assigns participants to a tested intervention. Its 1,798 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (247% higher).
The record links to 0 conditions, and to 1 intervention - of which Oxytocin is the first listed.
NCT00790062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00790062 about?
NCT00790062 is a clinical study titled "Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT". This is a double-blind 3-arm randomized clinical trial to determine whether higher dose oxytocin regimens (compared to the standard regimen) reduce the frequency of uterine atony and postpartum hemorrhage after vaginal delivery. Uterine atony is a loss of tone in the uterine musculature which can ca...
What is the current status of trial NCT00790062?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,798 participants. The study started on 2008-11. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00790062?
The interventions under investigation include: Oxytocin (DRUG).
Who is sponsoring clinical trial NCT00790062?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00790062's enrollment target sits among peer trials
1,798 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia